Organic chemist, pharmacologist, and drug designer. Exploring psychoactive substances, cognitive optimization, and harm reduction through scientific rigor and first-hand experience.
Alessio J. M. Rossini — organic chemist, drug designer, and lifelong explorer of psychoactive substances. Lugano, Switzerland. Born 1991.
A seasoned psychonaut, I have personally experimented with over 350 compounds — from Research Chemicals to NPS, from nootropics to performance enhancers. Not out of recklessness, but out of method: every molecule is a hypothesis to be tested.
My work merges cutting-edge pharmacology with hands-on experimentation. I promote raw, uncensored education on all psychoactive substances — rejecting stigma and arbitrary distinctions between molecules.
My spiritual mentors: Alexander “Sasha” Shulgin, David Nutt, David E. Nichols, and Albert Hofmann — whom I had the honor of visiting in 2009 during the production of the documentary “The Substance”.
For consultations, research collaborations, or harm-reduction oriented guidance, my time is available by appointment.
One-to-one consultations on pharmacology, harm reduction, nootropic and performance protocols, drug design and SAR. Pick a format below — booking happens right here.
Structured archive of pharmacology, psychoactive substances, mechanisms of action, receptor profiles, and applied knowledge. Not pop-science — analysis. 2,749 compounds, interactive interaction checker, 2D structures, and a navigable taxonomy tree.
Complete receptor profiles, binding affinities, selectivity profiles, signal transduction mechanisms. Every molecule mapped to its target with Ki/EC50 data when available.
From monoamines to glutamatergic systems, sigma receptors to endogenous opioids. Structured analysis by receptor class with SAR cross-references and clinical data.
Antidepressants, anxiolytics, antipsychotics, mood stabilizers. Mechanisms, PK/PD, interactions, and real-world safety profiles — not the sugarcoated data sheets.
Racetams, cholinergic modulators, mitochondrial enhancers, eugeroic compounds. Real evidence vs. marketing. Rational stacks based on mechanism, not hype.
NPS, designer drugs, structural analogs. Pharmacological profiles, SAR, first-hand reports. Territory where peer-reviewed literature doesn't reach — and where more rigor is needed, not less.
What you won't find elsewhere. Advanced protocols, documented high-risk combinations, real toxicity mechanisms. Only for those with the background to contextualize.
AAS, peptides, SARMs, GH secretagogues. Endocrine pharmacology applied to performance enhancement. Mechanisms, protocols, side effect management.
Three decades of research chemicals — chemistry-driven exploration, commercialization, regulatory pressure, and industrialized distribution. Navigate the phases.
From local synthesis to modular global logistics. Production, conversion, and distribution geographies have fragmented and specialized over three decades.
Pharmacology without the moral costume. Essays, doctrine, and harm-reduction from the mental laboratory.
Legal/illegal is the dumbest way to understand drugs.
Prohibition did not eliminate drugs. It outsourced pharmacology to criminals.
Bad language produces bad thinking. Bad thinking produces bad policy.
Familiarity is not mastery. Survival is not competence.
An open invitation to curious minds. Draw a structure — a hypothesis, a what-if, an analogue you can’t stop thinking about — and send it my way. The canvas is Ketcher (open-source): paste a SMILES or build from scratch, then fire it off as a creative prompt.
Paste a SMILES to load it, or draw on the canvas and pull the SMILES back out. When you have something worth sharing, hit Send this structure — it opens an encrypted message, pre-filled.
The actual binding site of amphetamines — not the dopamine receptor, but the dopamine transporter. Drosophila DAT crystallized with co-bound (+)-methamphetamine. Penmatsa, Wang & Gouaux, Nature 2015.
Technical analyses, advanced protocols, curated databases, and unreleased research. Access by invitation. PGP-authenticated session.
The path, unfiltered.
Visiting the discoverer of LSD during the filming of “The Substance”. An unrepeatable formative moment.
Systematic study of organic chemistry and synthesis. Early work on structure-activity relationships.
Over 200 compounds tested. Building a personal database of pharmacological profiles and subjective reports.
Launch of consulting practice. Integration of computational drug design and applied pharmacological analysis.
Launch of the digital platform. EncicloDOPEdia. Building a space where pharmacology meets operational truth.
For consultations, research, or collaborations. Private communications via encrypted channels.
Communications via ProtonMail and Telegram are end-to-end encrypted. I do not retain personal data beyond operational necessity.